Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release May 22 2024

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-may-22-2024-3

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated May 22, 2024, titled "Zydus receives final approval from USFDA for Theophylline Extended-Release Tablets, 300 mg and 450 mg".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases